Metraipolis › archive › dc_0218ae993e90

Association between extended-release buprenorphine adherence and reduced healthcare costs among insured patients with opioid use disorder — Europe PMC PMID:41869622

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41869622
DOI
10.3389/fpubh.2026.1774410
License (as archived)
solo-consultazione
Archived
2026-11-05T03:36:32.747Z
SHA-256 of the archived text
d75eb910fcb79a205eab2cd557c8e24b242086b7396ecb0de97b31af11c517e8
Stable URL of this page
https://metraipolis.com/documento/dc_0218ae993e90

How to cite

Association between extended-release buprenorphine adherence and reduced healthcare costs among insured patients with opioid use disorder — Europe PMC PMID:41869622 — Europe PMC (en), https://europepmc.org/article/MED/41869622 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0218ae993e90 (Metraipolis archive dc_0218ae993e90, sha256 d75eb910fcb79a205eab2cd557c8e24b242086b7396ecb0de97b31af11c517e8)
BibTeX
@misc{dc0218ae993e90,
  title = {Association between extended-release buprenorphine adherence and reduced healthcare costs among insured patients with opioid use disorder — Europe PMC PMID:41869622},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41869622},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0218ae993e90; sha256 d75eb910fcb79a205eab2cd557c8e24b242086b7396ecb0de97b31af11c517e8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41869622. Agents can read the archived copy with the MCP tool read_document.